1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Central Nervous System Sarcoma: new trials by email Literature Review of Central Nervous System Sarcoma trials Research Report on Central Nervous System Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sunitinib in Sarcomas of the Central Nervous System Sunitinib, wGT3x-BT - Gliosarcoma, Central Nervous System Sarcoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2019-02-21 | 2022-04-19 |
Brain Neoplasms (1) · Gliosarcoma (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1)
Sunitinib (1)
National Cancer Institute (NCI) (1)
United States (1)